These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16865818)

  • 1. Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences.
    Inoue S; Howgate EM; Rowland-Yeo K; Shimada T; Yamazaki H; Tucker GT; Rostami-Hodjegan A
    Xenobiotica; 2006 Jun; 36(6):499-513. PubMed ID: 16865818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling.
    Barter ZE; Tucker GT; Rowland-Yeo K
    Clin Pharmacokinet; 2013 Dec; 52(12):1085-100. PubMed ID: 23818090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway.
    Feng S; Cleary Y; Parrott N; Hu P; Weber C; Wang Y; Yin OQ; Shi J
    Eur J Clin Pharmacol; 2015 May; 71(5):617-24. PubMed ID: 25801493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
    Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
    Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling.
    Shiran MR; Proctor NJ; Howgate EM; Rowland-Yeo K; Tucker GT; Rostami-Hodjegan A
    Xenobiotica; 2006 Jul; 36(7):567-80. PubMed ID: 16864504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.
    Johnson TN; Boussery K; Rowland-Yeo K; Tucker GT; Rostami-Hodjegan A
    Clin Pharmacokinet; 2010 Mar; 49(3):189-206. PubMed ID: 20170207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability.
    Howgate EM; Rowland Yeo K; Proctor NJ; Tucker GT; Rostami-Hodjegan A
    Xenobiotica; 2006 Jun; 36(6):473-97. PubMed ID: 16769646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.
    Johnson TN; Rostami-Hodjegan A; Tucker GT
    Clin Pharmacokinet; 2006; 45(9):931-56. PubMed ID: 16928154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining 'Bottom-Up' and 'Top-Down' Methods to Assess Ethnic Difference in Clearance: Bitopertin as an Example.
    Feng S; Shi J; Parrott N; Hu P; Weber C; Martin-Facklam M; Saito T; Peck R
    Clin Pharmacokinet; 2016 Jul; 55(7):823-832. PubMed ID: 26715215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically-based pharmacokinetic model predictions of inter-ethnic differences in imatinib pharmacokinetics and dosing regimens.
    Adiwidjaja J; Gross AS; Boddy AV; McLachlan AJ
    Br J Clin Pharmacol; 2022 Feb; 88(4):1735-1750. PubMed ID: 34535920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients.
    Takahashi H; Wilkinson GR; Caraco Y; Muszkat M; Kim RB; Kashima T; Kimura S; Echizen H
    Clin Pharmacol Ther; 2003 Mar; 73(3):253-63. PubMed ID: 12621390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs.
    Mogi M; Toda A; Iwasaki K; Kusumoto S; Takehara H; Shimizu M; Murayama N; Izumi H; Utoh M; Yamazaki H
    J Toxicol Sci; 2012; 37(6):1157-64. PubMed ID: 23208431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tolbutamide in ethnic Chinese.
    Gross AS; Bridge S; Shenfield GM
    Br J Clin Pharmacol; 1999 Feb; 47(2):151-6. PubMed ID: 10190649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Utility of Physiologically-based Pharmacokinetic Model for prediction of Pharmacokinetics in Chinese and Japanese Populations.
    Yu Y; Lin J; Muto C; Li Y; Mori Y; Mittapalli RK; Tse S; Liu J; Ge BK; Liu J
    Int J Med Sci; 2021; 18(16):3718-3727. PubMed ID: 34790045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Unger S; Kawano K; Ahr G
    Br J Clin Pharmacol; 1998 Jun; 45(6):583-90. PubMed ID: 9663814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model.
    Cubitt HE; Yeo KR; Howgate EM; Rostami-Hodjegan A; Barter ZE
    Xenobiotica; 2011 Aug; 41(8):623-38. PubMed ID: 21434772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo.
    Donato MT; Hallifax D; Picazo L; Castell JV; Houston JB; Gomez-Lechón MJ; Lahoz A
    Drug Metab Dispos; 2010 Sep; 38(9):1449-55. PubMed ID: 20501911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.
    Bertilsson L
    Clin Pharmacokinet; 1995 Sep; 29(3):192-209. PubMed ID: 8521680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Shenxiong Glucose Injection on the Activities of Six CYP Isozymes and Metabolism of Warfarin in Rats Assessed Using Probe Cocktail and Pharmacokinetic Approaches.
    Sun J; Lu Y; Li Y; Pan J; Liu C; Gong Z; Huang J; Zheng J; Zheng L; Li Y; Liu T; Wang Y
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29156621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.